about
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to ad...
Read More
7.22
-0.59
(-7.55%)
65,060
XNAS Volume
High vol.+loss this week
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
LeonaBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..